免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

斯巴達胰島素輸液器

K 號:K243841 · 2025-08-01

決定日期2025-08-01
產品代碼FPA
諮詢委員會醫療設備規範文本翻譯如下: HO 注意:原文中未提供具體的醫療設備規範文本,因此上述翻譯僅為示例。請提供完整的規範文本以便進行準確翻譯。
決定相當於

器材摘要

Sparta Infusion Set for Insulin is the device name listed in this FDA 510(k) record. The listed applicant is Deka Research and Development. It received FDA 510(k) clearance on 2025-08-01 under 510(k) number K243841. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Sparta Infusion Set for Insulin?

Sparta Infusion Set for Insulin is a medical device that received FDA 510(k) clearance on 2025-08-01. The listed applicant is Deka Research and Development. The 510(k) number is K243841.

When did Sparta Infusion Set for Insulin receive FDA 510(k) clearance?

Sparta Infusion Set for Insulin received FDA 510(k) clearance on 2025-08-01, under 510(k) number K243841.

Who is the listed applicant for Sparta Infusion Set for Insulin?

The FDA 510(k) record lists Deka Research and Development as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Sparta Infusion Set for Insulin?

The FDA product code for Sparta Infusion Set for Insulin is FPA.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Deka Research and Development 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 15 項裝置 →

相關器械(代碼:FPA)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑